"Here, we present data on preclinical studies in mice of a receptor-binding domain (RBD)-based recombinant protein vaccine candidate (PHH-1V) consisting of an RBD fusion heterodimer comprising the B.1.351 and B.1.1.7 SARS-CoV-2 VoCs formulated in SQBA adjuvant, an oil-in-water emulsion."

#Preprint #SarsCov2 #vaccine #Preclinical

https://www.biorxiv.org/content/10.1101/2021.11.22.469117v6